Baxfendy approved for uncontrolled hypertension

morningstar.com·May 18, 2026 · 3 mesi fa

BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension

biopharmadive.com·May 18, 2026 · 3 mesi fa

FDA approves AstraZeneca’s new kind of hypertension drug

fiercepharma.com·May 18, 2026 · 3 mesi fa

AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too

endpoints.news·May 18, 2026 · 3 mesi fa

AstraZeneca's blood pressure pill approved, but competition could be around the corner

statnews.com·May 18, 2026 · 3 mesi fa

AstraZeneca picks up FDA approval for hypertension drug

endpoints.news·May 22, 2026 · 3 mesi fa

FDA grants Daiichi Sankyo and AstraZeneca’s Datroway a key breast cancer approval

morningstar.com·May 19, 2026 · 3 mesi fa

Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack

morningstar.com·May 21, 2026 · 3 mesi fa

Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease